Maria Rovithi

431 total citations
22 papers, 337 citations indexed

About

Maria Rovithi is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Maria Rovithi has authored 22 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Maria Rovithi's work include Colorectal Cancer Treatments and Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Renal cell carcinoma treatment (4 papers). Maria Rovithi is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Renal cell carcinoma treatment (4 papers). Maria Rovithi collaborates with scholars based in Netherlands, Greece and Italy. Maria Rovithi's co-authors include Henk M.W. Verheul, Godefridus J. Peters, Richard J. Honeywell, Arjan W. Griffioen, Elisa Giovannetti, Leticia G. León, Amir Avan, Thomas Würdinger, Niccola Funel and Dennis Poel and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Maria Rovithi

20 papers receiving 332 citations

Peers

Maria Rovithi

ONCOL

PRM

EPIDE

Patrizia Nardulli Italy

Shannon Zhang United States

Justin T. Moyers United States

Whitney P. Kirschbrown United States

J. Sigmond Netherlands

Junya Ohtake Japan

Elmira Gheytanchi Iran

Shaocong Wu China

Paula Dobosz Poland

Ester Fasoli Italy

Patrizia Nardulli Italy

Maria Rovithi

200 ×1.2

ONCOL

136 ×1.1

53 ×0.4

PRM

65 ×0.9

29 ×1.0

EPIDE

Citations per year, relative to Maria Rovithi Maria Rovithi (= 1×) peers Patrizia Nardulli

Countries citing papers authored by Maria Rovithi

Since Specialization

Citations

This map shows the geographic impact of Maria Rovithi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Rovithi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Rovithi more than expected).

Fields of papers citing papers by Maria Rovithi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Rovithi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Rovithi. The network helps show where Maria Rovithi may publish in the future.

Co-authorship network of co-authors of Maria Rovithi

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Rovithi. A scholar is included among the top collaborators of Maria Rovithi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Rovithi. Maria Rovithi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paraskeva, Miranda, et al.. (2024). The implementation of palliative care in Greece: a position paper by the Palliative Care Working Group of the Hellenic society of Medical Oncology (HeSMO). SHILAP Revista de lepidopterología. 15(1). 4–13.

Honeywell, Richard J., Ietje Kathmann, Elisa Giovannetti, et al.. (2020). Epithelial Transfer of the Tyrosine Kinase Inhibitors Erlotinib, Gefitinib, Afatinib, Crizotinib, Sorafenib, Sunitinib, and Dasatinib: Implications for Clinical Resistance. Cancers. 12(11). 3322–3322. 16 indexed citations

Zandvliet, Anthe S., Maria Rovithi, Richard J. Honeywell, et al.. (2020). Sorafenib administered using a high-dose, pulsatile regimen in patients with advanced solid malignancies: a phase I exposure escalation study. Cancer Chemotherapy and Pharmacology. 85(5). 931–940. 12 indexed citations

Rovithi, Maria, Richard J. Honeywell, Albert J. ten Tije, et al.. (2018). Phase I Dose-Escalation Study of Once Weekly or Once Every Two Weeks Administration of High-Dose Sunitinib in Patients With Refractory Solid Tumors. Journal of Clinical Oncology. 37(5). 411–418. 13 indexed citations

Werf, A. van der, Maria Rovithi, J.A.E. Langius, M.A.E. de van der Schueren, & Henk M.W. Verheul. (2017). Insight in taste alterations during treatment with protein kinase inhibitors. European Journal of Cancer. 86. 125–134. 18 indexed citations

Rovithi, Maria, Amir Avan, Niccola Funel, et al.. (2017). Development of bioluminescent chick chorioallantoic membrane (CAM) models for primary pancreatic cancer cells: a platform for drug testing. Scientific Reports. 7(1). 44686–44686. 71 indexed citations

Rovithi, Maria & Henk M.W. Verheul. (2017). Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity. Angiogenesis. 20(3). 287–289. 8 indexed citations

León, Leticia G., Maria Rovithi, Amir Avan, et al.. (2017). Development of bioluminescent chick chorioallantoic membrane (CAM) models from primary pancreatic cancer cells: A platform for drug testing. Pancreatology. 17(3). S16–S16. 2 indexed citations

Rovithi, Maria, Mariëtte Labots, Richard J. Honeywell, et al.. (2017). A phase 1/2 study of intermittent, high dose sunitinib in patients with advanced solid tumors.. Journal of Clinical Oncology. 35(15_suppl). 2591–2591. 1 indexed citations

10.

Rovithi, Maria, Richard R. de Haas, Richard J. Honeywell, et al.. (2016). Alternative scheduling of pulsatile, high dose sunitinib efficiently suppresses tumor growth. Journal of Experimental & Clinical Cancer Research. 35(1). 138–138. 18 indexed citations

11.

Rovithi, Maria, Joline S.W. Lind, Thang V. Pham, et al.. (2016). Response and toxicity prediction by MALDI‐TOF‐MS serum peptide profiling in patients with non‐small cell lung cancer. PROTEOMICS - CLINICAL APPLICATIONS. 10(7). 743–749. 6 indexed citations

12.

Gotink, Kristy J., Maria Rovithi, Richard R. de Haas, et al.. (2015). Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib. Cellular Oncology. 38(2). 119–129. 46 indexed citations

13.

Rovithi, Maria, Richard R. de Haas, Richard J. Honeywell, et al.. (2014). Abstract 2989: High-dose, intermittent sunitinib as an alternative treatment strategy. Cancer Research. 74(19_Supplement). 2989–2989. 1 indexed citations

14.

Hatzidaki, Dora, Ioannis Varthalitis, Nikolaos Kentepozidis, et al.. (2013). A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group. Journal of Chemotherapy. 25(1). 49–55. 40 indexed citations

15.

Labots, Mariëtte, Maarten Neerincx, Johannes C. van der Mijn, et al.. (2013). Tumor, skin, and plasma concentrations of protein kinase inhibitors (PKIs) in patients with advanced cancer.. Journal of Clinical Oncology. 31(15_suppl). 11087–11087. 2 indexed citations

16.

Rovithi, Maria, Athanasios Pallis, A. Kalykaki, et al.. (2011). Small Cell Ovarian Cancer in Adolescents: Report of Two Cases and Review of the Literature. Case Reports in Medicine. 2011. 1–4. 5 indexed citations

17.

Pallis, Athanasios, Nikolaos Xenidis, Ioannis Varthalitis, et al.. (2010). A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLC. Cancer Chemotherapy and Pharmacology. 67(6). 1239–1245. 17 indexed citations

18.

Polyzos, Aris, Nikolaos Kentepozidis, Stylianos Giassas, et al.. (2010). Second-line chemotherapy with Capecitabine (Xeloda) and Docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trial. Cancer Chemotherapy and Pharmacology. 67(2). 361–368. 24 indexed citations

19.

Samonis, George, Sofia Maraki, Konstantinos Leventakos, et al.. (2006). Effects of vancomycin, teicoplanin, linezolid, quinupristin-dalfopristin, and telithromycin on murine gut colonization byCandida albicans. Medical Mycology. 44(2). 193–196. 9 indexed citations

20.

Maraki, Sofia, Yiannis Tselentis, E. Koumantakis, et al.. (2003). Effects of Doxycycline, Metronidazole and their Combination onCandidaspecies Colonization of the Human Oropharynx, Intestinal Lumen and Vagina. Journal of Chemotherapy. 15(4). 369–373. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact